Latest Insider Transactions at Intuitive Surgical Inc (ISRG)
This section provides a real-time view of insider transactions for Intuitive Surgical Inc (ISRG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTUITIVE SURGICAL INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTUITIVE SURGICAL INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 10
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
104
-100.0%
|
$58,136
$559.9 P/Share
|
|
Dec 10
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
104
+50.0%
|
$23,816
$229.39 P/Share
|
|
Dec 01
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
125
-100.0%
|
$71,000
$568.99 P/Share
|
|
Dec 01
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125
+50.0%
|
$26,000
$208.9 P/Share
|
|
Dec 01
2025
|
Gary S Guthart Executive Chair of the Board o |
SELL
Open market or private sale
|
Direct |
22,806
-89.44%
|
$12,999,420
$570.89 P/Share
|
|
Dec 01
2025
|
Gary S Guthart Executive Chair of the Board o |
BUY
Exercise of conversion of derivative security
|
Direct |
25,500
+50.0%
|
$3,544,500
$139.52 P/Share
|
|
Nov 12
2025
|
Henry L Charlton EVP & Chief Commercial and Mkt |
SELL
Open market or private sale
|
Direct |
13,731
-29.47%
|
$7,963,980
$580.0 P/Share
|
|
Nov 12
2025
|
Henry L Charlton EVP & Chief Commercial and Mkt |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+17.39%
|
$2,277,000
$253.34 P/Share
|
|
Nov 12
2025
|
Craig H Barratt Director |
SELL
Open market or private sale
|
Direct |
750
-100.0%
|
$435,000
$580.0 P/Share
|
|
Nov 12
2025
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
750
+50.0%
|
$53,250
$71.32 P/Share
|
|
Nov 12
2025
|
Keith R Leonard Director |
SELL
Bona fide gift
|
Direct |
1,606
-68.49%
|
-
|
|
Nov 10
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
105
-100.0%
|
$58,800
$560.0 P/Share
|
|
Nov 10
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
105
+50.0%
|
$24,045
$229.39 P/Share
|
|
Nov 10
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
SELL
Open market or private sale
|
Direct |
3,500
-23.03%
|
$2,012,500
$575.0 P/Share
|
|
Nov 10
2025
|
Brian Edward Miller EVP & Chief Digital Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+18.6%
|
$766,500
$219.14 P/Share
|
|
Nov 05
2025
|
Fredrik Widman VP Corporate Controller |
SELL
Open market or private sale
|
Direct |
2,067
-52.65%
|
$1,136,850
$550.0 P/Share
|
|
Nov 05
2025
|
Fredrik Widman VP Corporate Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
2,067
+32.29%
|
$140,556
$68.23 P/Share
|
|
Nov 03
2025
|
David J. Rosa Chief Executive Officer (CEO) |
SELL
Bona fide gift
|
Direct |
5,454
-2.33%
|
-
|
|
Oct 29
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
125
-100.0%
|
$67,875
$543.0 P/Share
|
|
Oct 29
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125
+50.0%
|
$26,000
$208.9 P/Share
|
|
Oct 28
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
7,562
-83.21%
|
$4,143,976
$548.43 P/Share
|
|
Oct 28
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,562
+45.33%
|
$1,709,012
$226.88 P/Share
|
|
Oct 24
2025
|
Gary S Guthart Executive Chair of the Board o |
SELL
Open market or private sale
|
Indirect |
2,800
-7.56%
|
$1,528,800
$546.26 P/Share
|
|
Oct 24
2025
|
Gary S Guthart Executive Chair of the Board o |
SELL
Open market or private sale
|
Direct |
28,800
-51.59%
|
$15,753,600
$547.56 P/Share
|
|
Oct 24
2025
|
Gary S Guthart Executive Chair of the Board o |
BUY
Exercise of conversion of derivative security
|
Direct |
36,000
+39.2%
|
$3,924,000
$109.49 P/Share
|
|
Oct 24
2025
|
Craig H Barratt Director |
SELL
Open market or private sale
|
Direct |
2,193
-100.0%
|
$1,201,764
$548.01 P/Share
|
|
Oct 24
2025
|
Craig H Barratt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,193
+50.0%
|
$155,703
$71.32 P/Share
|
|
Oct 24
2025
|
David J. Rosa Chief Executive Officer (CEO) |
SELL
Open market or private sale
|
Direct |
24,500
-9.47%
|
$13,401,500
$547.55 P/Share
|
|
Oct 24
2025
|
David J. Rosa Chief Executive Officer (CEO) |
BUY
Exercise of conversion of derivative security
|
Direct |
27,000
+9.45%
|
$2,133,000
$79.64 P/Share
|
|
Oct 10
2025
|
Gary Loeb EVP & Chief Legal and Complian |
SELL
Payment of exercise price or tax liability
|
Direct |
1,296
-26.68%
|
$574,128
$443.76 P/Share
|
|
Oct 10
2025
|
Gary Loeb EVP & Chief Legal and Complian |
BUY
Exercise of conversion of derivative security
|
Direct |
2,612
+34.97%
|
-
|
|
Sep 04
2025
|
Amy L Ladd Director |
SELL
Open market or private sale
|
Direct |
335
-31.19%
|
$147,400
$440.69 P/Share
|
|
Sep 03
2025
|
Amy L Ladd Director |
SELL
Open market or private sale
|
Direct |
336
-23.83%
|
$157,920
$470.11 P/Share
|
|
Aug 29
2025
|
Gary S Guthart Executive Chair of the Board o |
SELL
Open market or private sale
|
Direct |
29,360
-59.69%
|
$13,857,920
$472.49 P/Share
|
|
Aug 29
2025
|
Gary S Guthart Executive Chair of the Board o |
BUY
Exercise of conversion of derivative security
|
Direct |
36,000
+42.26%
|
$2,844,000
$79.64 P/Share
|
|
Jul 28
2025
|
Gary S Guthart Executive Chair of the Board o |
SELL
Bona fide gift
|
Indirect |
10,500
-0.86%
|
-
|
|
Jul 28
2025
|
Gary S Guthart Executive Chair of the Board o |
SELL
Open market or private sale
|
Indirect |
2,800
-7.03%
|
$1,386,000
$495.24 P/Share
|
|
Jul 28
2025
|
Gary S Guthart Executive Chair of the Board o |
SELL
Open market or private sale
|
Direct |
7,893
-37.44%
|
$3,930,714
$498.64 P/Share
|
|
Jul 28
2025
|
Gary S Guthart Executive Chair of the Board o |
BUY
Exercise of conversion of derivative security
|
Direct |
7,893
+27.24%
|
$465,687
$59.46 P/Share
|
|
Jul 25
2025
|
Myriam Curet EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,500
-92.73%
|
$2,214,000
$492.48 P/Share
|
|
Jul 25
2025
|
Myriam Curet EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+48.11%
|
$1,089,000
$242.34 P/Share
|
|
Jun 10
2025
|
David J. Rosa Chief Executive Officer (CEO) |
SELL
Payment of exercise price or tax liability
|
Direct |
674
-0.29%
|
$354,524
$526.15 P/Share
|
|
Jun 10
2025
|
David J. Rosa Chief Executive Officer (CEO) |
BUY
Exercise of conversion of derivative security
|
Direct |
1,358
+0.58%
|
-
|
|
Jun 06
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
216
-19.23%
|
$121,608
$563.11 P/Share
|
|
Jun 05
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
215
-16.07%
|
$120,400
$560.7 P/Share
|
|
Jun 04
2025
|
David J. Rosa Chief Executive Officer (CEO) |
SELL
Bona fide gift
|
Direct |
851
-0.37%
|
-
|
|
Jun 04
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
215
-13.84%
|
$118,680
$552.07 P/Share
|
|
Jun 03
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
215
-12.16%
|
$118,250
$550.68 P/Share
|
|
Jun 02
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
215
-10.84%
|
$118,035
$549.06 P/Share
|
|
May 16
2025
|
Mark Brosius SVP & Chief Mfg and Supply Cha |
SELL
Open market or private sale
|
Direct |
20
-1.0%
|
$11,260
$563.81 P/Share
|